Form 4 for OMCL OMNICELL, INC.
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-14 · accession 0001415889-25-008372 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-18 | 2025-03-14 | OMCL | LIPPS RANDALL A | COB, Pres AND CEO, Dir | P - Purchase | $33.13 | +10.6K | 333.6K | +3% | +$349.9K | |
| 2025-03-18 | 2025-03-15 | OMCL | LIPPS RANDALL A | COB, Pres AND CEO, Dir | A - Grant | $0.00 | +79.5K | 413.1K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-14 | P | A | 10,561 | $33.13 | 333,610 | D | — | — | (F3) The price reported in Column 4 is a weighted average price of $33.1289 The purchase price range between $32.745 to $33.44 The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-03-15 | A | A | 79,494 | $0.00 | 413,104 | D | — | — | (F4) Restricted Stock Units granted in connection with the Issuer's equity incentive plan. One-fourth (25%) of the shares subject to the grant shall vest on March 15, 2026. The remaining three-fourths (75%) of the shares subject to the grant shall vest quarterly over three years on: (i) 5/15; (ii) 8/15; (iii) 11/15; and (iv) 2/15. |